Nagayama Y, Shigeno M, Nakagawa Y, Suganuma A, Takeshita A, Fujiyama K, Ashizawa K, Kiriyama T, Yokoyama N, Nagataki S (1994) Acquired nephrogenic diabetes insipidus secondary to distal renal tubular acidosis and nephrocalcinosis associated with Sjgrens syndrome
Our NAD+ therapies are physician-formulated, medically guided, and tailored to your goals, whether you're seeking more energy, deeper focus, or healthy aging support
Research suggests it promotes healing through upregulation of growth factors including VEGF (vascular endothelial growth factor), modulation of nitric oxide synthesis, and anti-inflammatory effects on multiple pathways
Potential applications: General age-related vision decline prevention as part of comprehensive anti-aging protocol
April 24, 2026 DSIP antioxidant research covering oxidative stress modulation, antioxidant enzyme activity, lipid peroxidation, and mitochondrial oxidative stress